negative control sirna Search Results


96
MedChemExpress si rna targeting nrf2
Si Rna Targeting Nrf2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/si rna targeting nrf2/product/MedChemExpress
Average 96 stars, based on 1 article reviews
si rna targeting nrf2 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

86
Thermo Fisher cho cells transfected construct sirna allstar negative control qiagen si03650318 control sirna
Cho Cells Transfected Construct Sirna Allstar Negative Control Qiagen Si03650318 Control Sirna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cho cells transfected construct sirna allstar negative control qiagen si03650318 control sirna/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
cho cells transfected construct sirna allstar negative control qiagen si03650318 control sirna - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

94
Qiagen anti his antibody alexa488 conjugate
Anti His Antibody Alexa488 Conjugate, supplied by Qiagen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti his antibody alexa488 conjugate/product/Qiagen
Average 94 stars, based on 1 article reviews
anti his antibody alexa488 conjugate - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Qiagen predesigned allstar negative control sirna
Predesigned Allstar Negative Control Sirna, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/predesigned allstar negative control sirna/product/Qiagen
Average 90 stars, based on 1 article reviews
predesigned allstar negative control sirna - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BONAC Corporation rnai negative control sirna
Rnai Negative Control Sirna, supplied by BONAC Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rnai negative control sirna/product/BONAC Corporation
Average 90 stars, based on 1 article reviews
rnai negative control sirna - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ST Pharm Co predesigned negative control sirna against gfp
Predesigned Negative Control Sirna Against Gfp, supplied by ST Pharm Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/predesigned negative control sirna against gfp/product/ST Pharm Co
Average 90 stars, based on 1 article reviews
predesigned negative control sirna against gfp - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Gene Universal Inc negative control sirna
Negative Control Sirna, supplied by Gene Universal Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/negative control sirna/product/Gene Universal Inc
Average 90 stars, based on 1 article reviews
negative control sirna - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Merck KGaA non-targeting sirna mission sirna universal control#1
Non Targeting Sirna Mission Sirna Universal Control#1, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-targeting sirna mission sirna universal control#1/product/Merck KGaA
Average 90 stars, based on 1 article reviews
non-targeting sirna mission sirna universal control#1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
B-Bridge Inc negative control sirna
Inhibition of p600 reduces the invasiveness of gastric cancer cells. a Effect of p600-targeting <t>siRNA</t> in the MKN45 gastric cancer cell line. ( i ) Reverse transcriptase–polymerase chain reaction (RT-PCR). ( ii ) Western blot test. b Effect of p600-targeting siRNA in the AGS gastric cancer cell line. ( i ) RT-PCR. ( ii ) Western blot test. β-Actin was used as the internal control for immunoblotting. p600 expression in both gastric cancer cell lines was inhibited by p600-targeting siRNA for at least 5 days. c ( i ) Microscopic appearance of the invading <t>control</t> <t>siRNA-transfected</t> MKN45 cells, and ( ii ) p600-targeting siRNA-transfected MKN45 cells . ( iii ) Number of invaded cells. d ( i ) Microscopic appearance of invading control siRNA-transfected AGS cells, and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Number of invaded cells. Data are expressed as mean ± SD. Inhibition of p600 reduced the invasiveness of both gastric cancer cell lines (MKN45, P = 0.004; AGS, P < 0.001). e Western blot analysis of urokinase-type plasminogen activator (uPA), matrix metalloproteinase (MMP)-2, MMP-7, and MMP-9 expression levels. ( i ) MKN45. ( ii ) AGS. β-Actin was used as the internal control for immunoblotting. MMP-7 expression was decreased by inhibition of p600 in both gastric cancer cell lines. f Western blot analysis of E-cadherin expression in MKN45 gastric cancer cells. β-Actin was used as the internal control for immunoblotting. Expression of E-cadherin was higher in p600-targeting siRNA-transfected MKN45 cells than in control siRNA-transfected MKN45 cells
Negative Control Sirna, supplied by B-Bridge Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/negative control sirna/product/B-Bridge Inc
Average 90 stars, based on 1 article reviews
negative control sirna - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Qiagen double-stranded sirnas to the selected regions of ac2-7
Inhibition of p600 reduces the invasiveness of gastric cancer cells. a Effect of p600-targeting <t>siRNA</t> in the MKN45 gastric cancer cell line. ( i ) Reverse transcriptase–polymerase chain reaction (RT-PCR). ( ii ) Western blot test. b Effect of p600-targeting siRNA in the AGS gastric cancer cell line. ( i ) RT-PCR. ( ii ) Western blot test. β-Actin was used as the internal control for immunoblotting. p600 expression in both gastric cancer cell lines was inhibited by p600-targeting siRNA for at least 5 days. c ( i ) Microscopic appearance of the invading <t>control</t> <t>siRNA-transfected</t> MKN45 cells, and ( ii ) p600-targeting siRNA-transfected MKN45 cells . ( iii ) Number of invaded cells. d ( i ) Microscopic appearance of invading control siRNA-transfected AGS cells, and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Number of invaded cells. Data are expressed as mean ± SD. Inhibition of p600 reduced the invasiveness of both gastric cancer cell lines (MKN45, P = 0.004; AGS, P < 0.001). e Western blot analysis of urokinase-type plasminogen activator (uPA), matrix metalloproteinase (MMP)-2, MMP-7, and MMP-9 expression levels. ( i ) MKN45. ( ii ) AGS. β-Actin was used as the internal control for immunoblotting. MMP-7 expression was decreased by inhibition of p600 in both gastric cancer cell lines. f Western blot analysis of E-cadherin expression in MKN45 gastric cancer cells. β-Actin was used as the internal control for immunoblotting. Expression of E-cadherin was higher in p600-targeting siRNA-transfected MKN45 cells than in control siRNA-transfected MKN45 cells
Double Stranded Sirnas To The Selected Regions Of Ac2 7, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/double-stranded sirnas to the selected regions of ac2-7/product/Qiagen
Average 90 stars, based on 1 article reviews
double-stranded sirnas to the selected regions of ac2-7 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Kaneka Corp non-specific sirna control
Real time RT-PCR analysis of pS2 transcripts in HeLa <t>and</t> <t>MBD2</t> -depleted HeLa cells (HeLa cells pretreated for 72 h with MBD2 <t>siRNA)</t> transfected with an MBD2 vector expressing a transcript resistant to RNAi (pRev-MBD2 vector) or with an empty basic vector pGL3. Transcriptional expression of pS2 was analyzed 24 h after transfection. The fold change of pS2 expression was calculated from the relative pS2 mRNA in pRev-MBD2-transfected cells compared to pGL3-transfected cells. Values are presented as the mean ± standard deviation of at least three independent transfection experiments. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).
Non Specific Sirna Control, supplied by Kaneka Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-specific sirna control/product/Kaneka Corp
Average 90 stars, based on 1 article reviews
non-specific sirna control - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Qiagen cntfr-sirna
Real time RT-PCR analysis of pS2 transcripts in HeLa <t>and</t> <t>MBD2</t> -depleted HeLa cells (HeLa cells pretreated for 72 h with MBD2 <t>siRNA)</t> transfected with an MBD2 vector expressing a transcript resistant to RNAi (pRev-MBD2 vector) or with an empty basic vector pGL3. Transcriptional expression of pS2 was analyzed 24 h after transfection. The fold change of pS2 expression was calculated from the relative pS2 mRNA in pRev-MBD2-transfected cells compared to pGL3-transfected cells. Values are presented as the mean ± standard deviation of at least three independent transfection experiments. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).
Cntfr Sirna, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cntfr-sirna/product/Qiagen
Average 90 stars, based on 1 article reviews
cntfr-sirna - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Inhibition of p600 reduces the invasiveness of gastric cancer cells. a Effect of p600-targeting siRNA in the MKN45 gastric cancer cell line. ( i ) Reverse transcriptase–polymerase chain reaction (RT-PCR). ( ii ) Western blot test. b Effect of p600-targeting siRNA in the AGS gastric cancer cell line. ( i ) RT-PCR. ( ii ) Western blot test. β-Actin was used as the internal control for immunoblotting. p600 expression in both gastric cancer cell lines was inhibited by p600-targeting siRNA for at least 5 days. c ( i ) Microscopic appearance of the invading control siRNA-transfected MKN45 cells, and ( ii ) p600-targeting siRNA-transfected MKN45 cells . ( iii ) Number of invaded cells. d ( i ) Microscopic appearance of invading control siRNA-transfected AGS cells, and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Number of invaded cells. Data are expressed as mean ± SD. Inhibition of p600 reduced the invasiveness of both gastric cancer cell lines (MKN45, P = 0.004; AGS, P < 0.001). e Western blot analysis of urokinase-type plasminogen activator (uPA), matrix metalloproteinase (MMP)-2, MMP-7, and MMP-9 expression levels. ( i ) MKN45. ( ii ) AGS. β-Actin was used as the internal control for immunoblotting. MMP-7 expression was decreased by inhibition of p600 in both gastric cancer cell lines. f Western blot analysis of E-cadherin expression in MKN45 gastric cancer cells. β-Actin was used as the internal control for immunoblotting. Expression of E-cadherin was higher in p600-targeting siRNA-transfected MKN45 cells than in control siRNA-transfected MKN45 cells

Journal: Annals of Surgical Oncology

Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer

doi: 10.1245/s10434-010-1523-0

Figure Lengend Snippet: Inhibition of p600 reduces the invasiveness of gastric cancer cells. a Effect of p600-targeting siRNA in the MKN45 gastric cancer cell line. ( i ) Reverse transcriptase–polymerase chain reaction (RT-PCR). ( ii ) Western blot test. b Effect of p600-targeting siRNA in the AGS gastric cancer cell line. ( i ) RT-PCR. ( ii ) Western blot test. β-Actin was used as the internal control for immunoblotting. p600 expression in both gastric cancer cell lines was inhibited by p600-targeting siRNA for at least 5 days. c ( i ) Microscopic appearance of the invading control siRNA-transfected MKN45 cells, and ( ii ) p600-targeting siRNA-transfected MKN45 cells . ( iii ) Number of invaded cells. d ( i ) Microscopic appearance of invading control siRNA-transfected AGS cells, and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Number of invaded cells. Data are expressed as mean ± SD. Inhibition of p600 reduced the invasiveness of both gastric cancer cell lines (MKN45, P = 0.004; AGS, P < 0.001). e Western blot analysis of urokinase-type plasminogen activator (uPA), matrix metalloproteinase (MMP)-2, MMP-7, and MMP-9 expression levels. ( i ) MKN45. ( ii ) AGS. β-Actin was used as the internal control for immunoblotting. MMP-7 expression was decreased by inhibition of p600 in both gastric cancer cell lines. f Western blot analysis of E-cadherin expression in MKN45 gastric cancer cells. β-Actin was used as the internal control for immunoblotting. Expression of E-cadherin was higher in p600-targeting siRNA-transfected MKN45 cells than in control siRNA-transfected MKN45 cells

Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or negative control siRNA (B-Bridge), which was confirmed not to target a specific array by electroporation with a Nucleofector System (Amaxa Biosystems, Koln, Germany) according to the manufacturer’s instructions.

Techniques: Inhibition, Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Western Blot, Expressing, Transfection

Inhibition of p600 does not affect cell proliferation, apoptosis, and colony-formation capacity under anchorage-dependent conditions. a Proliferation assay under anchorage-dependent conditions. There was no significant difference between p600 -targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of cell proliferation under anchorage-dependent conditions. b Proportion of apoptotic cells in ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells as analyzed by flow cytometry. There was no significant difference between p600-targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of apoptotic cells proportion. c Macroscopic appearance of colonies formed under anchorage-dependent conditions; ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600 - targeting siRNA-transfected MKN45 cells. ( iii ) Data graph. Data are expressed as mean ± SD. There was no significant difference between p600 -targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of colony-formation capacity under anchorage-dependent conditions

Journal: Annals of Surgical Oncology

Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer

doi: 10.1245/s10434-010-1523-0

Figure Lengend Snippet: Inhibition of p600 does not affect cell proliferation, apoptosis, and colony-formation capacity under anchorage-dependent conditions. a Proliferation assay under anchorage-dependent conditions. There was no significant difference between p600 -targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of cell proliferation under anchorage-dependent conditions. b Proportion of apoptotic cells in ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells as analyzed by flow cytometry. There was no significant difference between p600-targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of apoptotic cells proportion. c Macroscopic appearance of colonies formed under anchorage-dependent conditions; ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600 - targeting siRNA-transfected MKN45 cells. ( iii ) Data graph. Data are expressed as mean ± SD. There was no significant difference between p600 -targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of colony-formation capacity under anchorage-dependent conditions

Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or negative control siRNA (B-Bridge), which was confirmed not to target a specific array by electroporation with a Nucleofector System (Amaxa Biosystems, Koln, Germany) according to the manufacturer’s instructions.

Techniques: Inhibition, Proliferation Assay, Transfection, Flow Cytometry

Inhibition of p600 sensitizes gastric cancer cells to anoikis and reduces their viability under anchorage-independent conditions. a Cell viability assay under anchorage-independent conditions. The viability of ( i ) MKN45 and ( ii ) AGS gastric cancer cells were reduced by inhibition of p600 (MKN45, P = 0.033; AGS, P < 0.001). b Proportion of apoptotic (anoikis) cells under anchorage-independent conditions in ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells as analyzed by flow cytometry. c Proportion of apoptotic (anoikis) cells in ( i ) control siRNA-transfected AGS cells and ( ii ) p600-targeting siRNA-transfected AGS cells as analyzed by flow cytometry. d Macroscopic appearance of colonies formed in soft agar; ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells. ( iii ) Number of colonies. e Macroscopic appearance of colonies formed in soft agar; ( i ) control siRNA-transfected AGS cells and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Data graph. Data are expressed as mean ± SD. The number of colonies was reduced by inhibition of p600 (MKN45, P < 0.001; AGS, P = 0.003)

Journal: Annals of Surgical Oncology

Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer

doi: 10.1245/s10434-010-1523-0

Figure Lengend Snippet: Inhibition of p600 sensitizes gastric cancer cells to anoikis and reduces their viability under anchorage-independent conditions. a Cell viability assay under anchorage-independent conditions. The viability of ( i ) MKN45 and ( ii ) AGS gastric cancer cells were reduced by inhibition of p600 (MKN45, P = 0.033; AGS, P < 0.001). b Proportion of apoptotic (anoikis) cells under anchorage-independent conditions in ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells as analyzed by flow cytometry. c Proportion of apoptotic (anoikis) cells in ( i ) control siRNA-transfected AGS cells and ( ii ) p600-targeting siRNA-transfected AGS cells as analyzed by flow cytometry. d Macroscopic appearance of colonies formed in soft agar; ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells. ( iii ) Number of colonies. e Macroscopic appearance of colonies formed in soft agar; ( i ) control siRNA-transfected AGS cells and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Data graph. Data are expressed as mean ± SD. The number of colonies was reduced by inhibition of p600 (MKN45, P < 0.001; AGS, P = 0.003)

Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or negative control siRNA (B-Bridge), which was confirmed not to target a specific array by electroporation with a Nucleofector System (Amaxa Biosystems, Koln, Germany) according to the manufacturer’s instructions.

Techniques: Inhibition, Viability Assay, Transfection, Flow Cytometry

Inhibition of p600 suppresses the establishment of intraperitoneal disseminated tumors. a Macroscopic appearance of the intraperitoneal disseminated nodules; ( i ) control siRNA-transfected MKN45 cells injected into SCID mice, and ( ii ) p600-targeting siRNA-transfected MKN45 cells ( n = 10/group). Arrows indicate intraperitoneal disseminated nodules. ( iii ) Resected disseminated nodules from SCID mice. b Data graph. Data are expressed as mean ± SD. The number of intraperitoneal disseminated nodules was significantly reduced by p600 inhibition ( P < 0.001)

Journal: Annals of Surgical Oncology

Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer

doi: 10.1245/s10434-010-1523-0

Figure Lengend Snippet: Inhibition of p600 suppresses the establishment of intraperitoneal disseminated tumors. a Macroscopic appearance of the intraperitoneal disseminated nodules; ( i ) control siRNA-transfected MKN45 cells injected into SCID mice, and ( ii ) p600-targeting siRNA-transfected MKN45 cells ( n = 10/group). Arrows indicate intraperitoneal disseminated nodules. ( iii ) Resected disseminated nodules from SCID mice. b Data graph. Data are expressed as mean ± SD. The number of intraperitoneal disseminated nodules was significantly reduced by p600 inhibition ( P < 0.001)

Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or negative control siRNA (B-Bridge), which was confirmed not to target a specific array by electroporation with a Nucleofector System (Amaxa Biosystems, Koln, Germany) according to the manufacturer’s instructions.

Techniques: Inhibition, Transfection, Injection

Real time RT-PCR analysis of pS2 transcripts in HeLa and MBD2 -depleted HeLa cells (HeLa cells pretreated for 72 h with MBD2 siRNA) transfected with an MBD2 vector expressing a transcript resistant to RNAi (pRev-MBD2 vector) or with an empty basic vector pGL3. Transcriptional expression of pS2 was analyzed 24 h after transfection. The fold change of pS2 expression was calculated from the relative pS2 mRNA in pRev-MBD2-transfected cells compared to pGL3-transfected cells. Values are presented as the mean ± standard deviation of at least three independent transfection experiments. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).

Journal: PLoS ONE

Article Title: A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2 / TFF1 Gene

doi: 10.1371/journal.pone.0009665

Figure Lengend Snippet: Real time RT-PCR analysis of pS2 transcripts in HeLa and MBD2 -depleted HeLa cells (HeLa cells pretreated for 72 h with MBD2 siRNA) transfected with an MBD2 vector expressing a transcript resistant to RNAi (pRev-MBD2 vector) or with an empty basic vector pGL3. Transcriptional expression of pS2 was analyzed 24 h after transfection. The fold change of pS2 expression was calculated from the relative pS2 mRNA in pRev-MBD2-transfected cells compared to pGL3-transfected cells. Values are presented as the mean ± standard deviation of at least three independent transfection experiments. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).

Article Snippet: siRNA duplexes for MBD2 (sense: 5′-GGAGGAAGUGUACCGAAATT-3′ ; antisense: 5′-UUUUCGGAUCACUUCCUCCTT-3′ ) and non-specific siRNA control were obtained from Eurogentec (Eurogentec, Seraing, Belgium).

Techniques: Quantitative RT-PCR, Transfection, Plasmid Preparation, Expressing, Standard Deviation

( A ) Transcriptional expression of pS2 was analyzed using relative RT-PCR in HeLa cells expressing ERα and/or depleted in MBD2. Mock, mock-treated HeLa cells. ER, HeLa cells 24 h after transfection with a human ERα expression vector, HEG0. MBD2 siRNA, HeLa cells pretreated for 72 h with MBD2 siRNA and again for 24 h. MBD2 siRNA + ER, HeLa cells pretreated for 72 h with MBD2 siRNA, then cotransfected with MBD2 siRNA and HEG0 for 24 h. OHT, 24 h treatment with 4-hydroxytamoxifen. MCF7, MCF7 cells. ( B ) Bar chart showing the fold change of pS2 expression in HeLa cells expressing ERα and/or depleted in MBD2. pS2 transcripts were quantified by real time RT-PCR. The fold change was calculated from the relative pS2 mRNA in treated compared to mock-treated cells. Each bar represents the mean ± standard deviation of three analyses. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).

Journal: PLoS ONE

Article Title: A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2 / TFF1 Gene

doi: 10.1371/journal.pone.0009665

Figure Lengend Snippet: ( A ) Transcriptional expression of pS2 was analyzed using relative RT-PCR in HeLa cells expressing ERα and/or depleted in MBD2. Mock, mock-treated HeLa cells. ER, HeLa cells 24 h after transfection with a human ERα expression vector, HEG0. MBD2 siRNA, HeLa cells pretreated for 72 h with MBD2 siRNA and again for 24 h. MBD2 siRNA + ER, HeLa cells pretreated for 72 h with MBD2 siRNA, then cotransfected with MBD2 siRNA and HEG0 for 24 h. OHT, 24 h treatment with 4-hydroxytamoxifen. MCF7, MCF7 cells. ( B ) Bar chart showing the fold change of pS2 expression in HeLa cells expressing ERα and/or depleted in MBD2. pS2 transcripts were quantified by real time RT-PCR. The fold change was calculated from the relative pS2 mRNA in treated compared to mock-treated cells. Each bar represents the mean ± standard deviation of three analyses. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).

Article Snippet: siRNA duplexes for MBD2 (sense: 5′-GGAGGAAGUGUACCGAAATT-3′ ; antisense: 5′-UUUUCGGAUCACUUCCUCCTT-3′ ) and non-specific siRNA control were obtained from Eurogentec (Eurogentec, Seraing, Belgium).

Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Transfection, Plasmid Preparation, Quantitative RT-PCR, Standard Deviation